Sanjad's effect on osteoporotic pain in menopausal wome
Phase 3
Completed
- Conditions
- osteoarthritis.
- Registration Number
- IRCT20180122038472N1
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
Menopausal patients aged 40-80 years. who have osteoarthritis according to the clinical and radiological criteria of the American College of Rheumatology.
In active movements of the knee, they experience pain (40 mm from the criterion of 100 mm VAS) and have back pain.
Back pain
Exclusion Criteria
Musculoskeletal disorders
uncontrolled hypertension
receiving steroids
diabetes
Body mass index greater than or equal to 30
Hysterectomy and ovarectomy
class 3 and 4 heart disease
hyperthyroidism
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of pain. Timepoint: Before research, after 4 and 8 weeks. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Elaeagnus angustifolia's analgesic effects in osteoarthritis?
How does Elaeagnus angustifolia compare to NSAIDs in managing postmenopausal osteoarthritis pain?
Are there specific biomarkers that predict response to Elaeagnus angustifolia in osteoporotic patients?
What adverse events are associated with Elaeagnus angustifolia stone extract in clinical trials?
What combination therapies show promise with Elaeagnus angustifolia for osteoarthritis treatment?